Email this article 
Antibacterial Actinomycetes from Tropical Ecosystem Karst in South Sulawesi: Isolation, Characterization, and Bioactive Metabolite Profiling
Abstract
The emergence of antimicrobial-resistant pathogens reinforces the critical need for new antibiotics sourced from unexplored microbial habitats. Actinomycetes remain the most prolific bacterial producers of bioactive secondary metabolites, yet tropical karst ecosystems and plant-associated rhizospheres in Indonesia remain poorly investigated despite their ecological complexity. This study aimed to isolate, screen, and characterize Actinomycetes from the karst and rhizospheric environments of South Sulawesi, Indonesia, and to identify isolates capable of producing antibacterial compounds. A total of 42 isolates were obtained using heat-shock pretreatment and selective Starch Casein Agar. Preliminary antagonistic assays against Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 35218 identified four active isolates. Two isolates KMR 1E2 and SDR 2a exhibited strong inhibition (>30 mm) against S. aureus, while SDR 9.9 inhibited E. coli. Morphological and phenotypic characterization revealed diverse spore-chain architectures, colony color profiles, carbon and nitrogen utilization patterns, salinity tolerance, melanin production, and variable growth under different pH and temperature conditions. Ethyl acetate extracts of KMR 1E2 and SDR 2a demonstrated potent antibacterial activity, and TLC-bioautography identified three active metabolites (Rf 0.73, 0.48, 0.34), with the Rf 0.34 spot associated with an alkaloid-type compound. The minimum inhibitory concentration (MIC) of KMR 1E2 extract against S. aureus was 0.3125 mg/mL. This study confirms that tropical karst ecosystems in Indonesia are promising reservoirs of antibiotic-producing Actinomycetes and provides a foundation for future genomic and chemical elucidation studies
Keywords
Full Text:
PDFReferences
Abdelmohsen, U. R., et al. (2018). Actinomycetes from unexplored environments as a source of novel bioactive compounds. Frontiers in Microbiology, 9, 222.
Al-Dhabi, N. A., Esmail, G. A., & Arasu, M. V. (2022). Antimicrobial potential of Actinomycetes-derived alkaloids from extreme environments. Frontiers in Microbiology, 13, 897215.
Alanjary, M., Selem-Mojica, N., Sarkar, N., et al. (2022). Mining microbial genomes for biosynthetic gene clusters. Nature Reviews Microbiology, 20(2), 103-118.
Ali, A., Passitta, M., Rante, H., Wahyudin, E., Djide, N. J. N., Politan, R. J., Nur, E. A., Shigeno, S., Ohte, S., Kobayashi, K., Hosoda, K., Tomoda, H., & Ohshiro, T. (2024). Antibiotic production by an endophytic Streptomyces isolated from the medicinal plant Poikilospermum suaveolens. Biodiversitas, 25(5), 2221–2229. https://doi.org/10.13057/biodiv/d250540
Awad, G., et al. (2020). Novel alkaloid compounds from cave-derived Actinomycetes. Scientific Reports, 10, 12527.
Awad, G., et al. (2020). Antibacterial alkaloids from cave-derived Actinomycetes. Journal of Antibiotics, 73, 265-74.
Baltz, R. H. (2021). Natural product discovery from Actinomycetes: Past, present, and future. Antibiotics, 10, 34.
Chen, Y., Chen, Z., Sun, L., et al. (2021). Antibacterial metabolites from environmental Actinomycetes: A global screening. Journal of Applied Microbiology, 131(1), 45-56.
Cruz-Morales, P., Orellana, C. A., Moutafis, G., et al. (2019). Evolution and functional significance of specialized metabolism in Actinobacteria. Cell Reports, 29(12), 3721-3735.
Federspiel, N. A., et al. (2022). Advances in genomics-driven activation of cryptic biosynthetic gene clusters in Actinomycetes. Applied Microbiology and Biotechnology, 106(9), 3789-3802.
Genilloud, O. (2018). Actinomycetes: Still a source of novel antibiotics. Microbial Biotechnology, 11(3), 588-605.
Genilloud, O. (2019). Actinomycetes as a source of antimicrobial agents. Microbial Biotechnology, 12, 828-840.
Heng, N. C., Yoon, J., & Choi, J. (2021). Antibacterial activity of soil-derived Streptomyces isolates. AIMS Microbiology, 7, 46-64.
Hu, Y., Cheng, H., Lu, Z., & Zhou, C. (2020). Discovery of potent antibacterial compounds from environmental Actinomycetes. Antibiotics, 9, 632.
Huang, T., Wang, L., Zhang, Y., et al. (2023). Broad-spectrum antibacterial metabolites from karst-derived Actinobacteria. Microorganisms, 11, 1645.
Jiang, Y., et al. (2020). Microbial diversity in karst ecosystems: Implications for biotechnology. Applied Microbiology and Biotechnology, 104, 6369-6383.
Kalam, S., Singh, R., & Verma, P. (2020). Halotolerant Actinomycetes and their potential antimicrobial metabolites. Frontiers in Microbiology, 11, 576708.
Kaur, T., Kumari, M., & Singh, D. (2020). Diversity and activities of rhizosphere Actinobacteria. Rhizosphere, 16, 100255.
Komaki, H., Tamura, T., & Suzuki, K. (2020). Morphological diversity and taxonomy of Streptomyces. Systematic and Applied Microbiology, 43, 126146.
Kyeremeh, K., Acquah, K. S., & Osei, H. (2021). Multi-metabolite antibacterial activity from Actinomycetes in extreme habitats. Antibiotics, 10, 335.
Li, J., Zhang, L., & Chen, X. (2022). Metagenomic insights into microbial communities of karst ecosystems. Environmental Microbiology, 24, 3695-3710.
Li, X., Yan, Y., & Wang, Z. (2024). Modern approaches for Actinomycete classification and metabolite prediction. Current Microbiology, 81, 26.
Ma, X., Liu, Q., & Zhao, W. (2022). Antibacterial metabolites from limestone-associated Actinobacteria. Frontiers in Pharmacology, 13, 85442.
Santos, J. C., Alves, L., & Costa, R. (2021). Melanin-producing Actinomycetes: Stress protection and implications for secondary metabolism. Microbial Ecology, 82, 955-967.
Sharma, N., Thakur, D., & Chandel, S. (2020). Antibacterial potential of terrestrial Streptomyces isolates. Journal of King Saud University Science, 32, 2188-2195.
Sunaryanto, R., Bambang, M., & Yoshihide, M. (2010). Isolasi Actinomycetes laut penghasil metabolit sekunder aktif terhadap sel kanker A549. Jurnal Pascapanen dan Bioteknologi Kelautan dan Perikanan, 5(2), 65-74.
Tao, L., Lin, C., & Huang, Y. (2023). Metabolic rewiring associated with melanin production in Streptomyces. Frontiers in Microbiology, 14, 1134051.
Ventola, C. (2020). The antibiotic resistance crisis: Causes and threats. Pharmacy and Therapeutics, 45, 82-89.
Wang, Q., Wang, Z., & Liu, X. (2024). Adaptive evolution of Actinomycetes in mineral-rich ecosystems. mBio, 15, e00822-24.
Wang, Z., Chen, Y., & Li, D. (2023). Karst Actinomycetes and their antimicrobial metabolites. Microbial Ecology, 85, 1231-1244.
Wang, Z., Liu, X., & Chen, Y. (2024). Evolutionary adaptations of Actinobacteria in mineral-stressed karst biomes. mBio, 15(1), e00822-24
World Health Organization. (2023). WHO bacterial priority pathogens list for R&D of new antibiotics. WHO, Geneva.
Zhang, Y., Zhou, X., & Zeng, J. (2021). Diversity and bioactivity of Actinobacteria from Asian karst biomes. Frontiers in Microbiology, 12, 687102.
Zhang, T., Chen, L., & Wu, Y. (2023). Novel antimicrobial compounds from cave Actinomycetes. Microorganisms, 11, 663.
Zhou, X., Li, M., & Liu, Y. (2020). Biosynthetic potential of karst microbial communities. Scientific Reports, 10, 21147.
DOI: https://doi.org/10.14421/biomedich.2026.151.253-262
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Alimuddin Ali, Pasmawati Pasmawati, Rukman Muslimin, Alnadia Yusriya Hibatullah, Deni Frans Sakka, Christina Aryanti Pada Soa, Kusdianawati Buhaerah, Muharram Passitta
Biology, Medicine, & Natural Product Chemistry |
|
